Minoxidil is the most widely used treatment for hair loss, and clinical trials consistently show it works, though not equally for everyone. In a 48-week trial, the 5% concentration produced 45% more hair regrowth than the 2% version, which itself outperformed placebo. Most users see some improvement, but the degree varies significantly based on individual biology, how long hair loss has been progressing, and how consistently the treatment is applied.
How Minoxidil Stimulates Hair Growth
Minoxidil was originally developed as a blood pressure medication. Researchers noticed an unexpected side effect: patients were growing hair in places they hadn’t before. That observation led to its reformulation as a hair loss treatment, and the underlying mechanism explains both its benefits and its limitations.
Hair follicles cycle through phases: a growth phase, a transition phase, and a resting phase. In pattern hair loss, follicles spend progressively more time resting and less time growing, producing thinner, shorter hairs with each cycle. Minoxidil interrupts this process in two ways. First, it shortens the resting phase, pushing dormant follicles back into active growth sooner than they would on their own. Second, it extends the growth phase, giving each hair more time to reach full length and thickness. It also acts directly on the cells at the base of the follicle, functioning as a growth factor that slows their aging.
Critically, minoxidil is a pro-drug. Your body has to convert it into its active form (minoxidil sulfate) before it can do anything. This conversion happens inside the hair follicle itself, and the enzyme responsible for it varies enormously from person to person. That enzyme activity is the single biggest factor determining whether minoxidil will work for you.
What the Numbers Show for Men
The landmark clinical trial comparing 5% and 2% topical minoxidil in men with pattern hair loss ran for 48 weeks. At the end, 5% minoxidil was significantly superior to both the 2% version and placebo across every measure: actual hair counts, patient-rated scalp coverage, and investigator assessments. The 5% group saw 45% more regrowth than the 2% group, making the higher concentration the standard recommendation for men.
These results reflect averages across large groups. Some men see dramatic regrowth, filling in noticeably thin areas. Others experience a more modest outcome: the hair they have gets thicker and the rate of loss slows, but bald patches don’t fully recover. In general, minoxidil works best on areas that still have miniaturized (thin, wispy) hairs rather than areas that have been completely smooth for years. Follicles that have been dormant too long may be beyond rescue.
Effectiveness in Women
Women typically experience a different pattern of hair loss, with diffuse thinning across the top of the scalp rather than a receding hairline. A randomized trial comparing 1 mg oral minoxidil to 5% topical minoxidil in women found both forms effective. After 24 weeks, oral minoxidil increased total hair density by 12%, while the topical version increased it by 7.2%. Both improvements were statistically significant compared to baseline, though the difference between the two forms was not large enough to be statistically meaningful.
In that same trial, 70% of women taking oral minoxidil showed visible improvement in photographs, compared to 46% using the topical solution. Nearly half the women in the topical group showed no change at all on photographic assessment. Quality of life scores improved substantially in both groups, with women in the oral group trending slightly better.
Oral Versus Topical Forms
Low-dose oral minoxidil has gained significant traction in recent years. An expert consensus panel of 43 dermatologists specializing in hair loss, representing 12 countries, agreed that oral minoxidil may be preferred over topical in several situations: when topical application is inconvenient, when the topical form causes scalp irritation, or when cost is a factor.
The practical appeal is straightforward. Topical minoxidil needs to be applied directly to the scalp once or twice daily, can leave a greasy or sticky residue, and sometimes causes contact irritation. A small daily pill eliminates those issues entirely. The clinical data suggest oral minoxidil performs at least as well as topical, and possibly slightly better in women, though head-to-head trials are still limited in number.
Timeline From Start to Results
Minoxidil doesn’t produce overnight results, and the first few weeks can feel discouraging. Around 3 to 6 weeks after starting treatment, many users notice increased shedding. This “dread shed” happens because minoxidil is pushing resting follicles into growth mode ahead of schedule, which means the old hairs fall out before the new ones have emerged. The shedding typically resolves within 4 to 6 weeks of onset.
First signs of new growth usually appear around 6 to 8 weeks. These early hairs are often fine and light in color, gradually thickening over time. Hair growth peaks between 12 and 16 weeks, though many users continue to see incremental improvement for up to a year. The 48-week trial data suggests that results at 4 months are noticeable but not yet maximal. Patience matters: people who quit at the 2-month mark often haven’t given the treatment enough time to show what it can do.
Why Some People Don’t Respond
Roughly 30 to 50% of users see limited or no benefit from topical minoxidil, and the reason comes down to enzyme activity in the scalp. Minoxidil must be converted into its sulfated form by a specific enzyme in the hair follicle. The expression of this enzyme varies dramatically between individuals. In research testing, an assay measuring enzyme activity was able to predict minoxidil responders with 95% sensitivity and 73% specificity. People with higher enzyme activity respond well; those with low activity get little benefit.
There appears to be a continuum rather than a simple on/off switch. Women with moderately low enzyme activity saw only minor hair growth, while those with robust enzyme levels saw much stronger results. Interestingly, regular aspirin use may suppress this enzyme. In one study, 50% of subjects were initially predicted to respond to minoxidil, but after 14 days of aspirin use, only 27% were still predicted to benefit. If you take aspirin daily and minoxidil doesn’t seem to be working, that interaction is worth considering.
On the flip side, topical tretinoin (a vitamin A derivative commonly used for skin) may boost the enzyme’s activity. In one cohort, 43% of subjects initially predicted to be non-responders were reclassified as likely responders after just 5 days of topical tretinoin application. This is why some dermatologists prescribe the two together.
The Maintenance Requirement
Minoxidil does not cure hair loss. It manages it. The regrowth you achieve depends on continued use, and stopping treatment reverses the gains. All newly grown hairs will fall out within months of discontinuation as follicles revert to their shortened growth cycles. This is not a rebound effect or a sign of damage. It simply means the underlying pattern hair loss, which minoxidil was counteracting, resumes its natural progression.
This is the most important thing to understand before starting: minoxidil is a long-term, potentially lifelong commitment. If you’re not prepared to apply it consistently (or take it orally) for years, the temporary regrowth may not feel worth the effort. For those who do maintain the routine, it remains one of the most effective non-surgical options available for slowing hair loss and recovering some of what’s been lost.